474 Results (Page 12 of 19)
Egypt Markets Research Reports
Egypt Liver Disease Drugs Market Analysis
This report presents a strategic analysis of the Egypt Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Liver Disease Drugs Market, offering unmatched value, accuracy, and expert insights.
Egypt Healthcare Claims Management Market Analysis
Egypt's healthcare claims management market is projected to grow from $74.76 Mn in 2022 to $442.76 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022-30. The main factors driving the growth would be rising health insurance coverage, increasing patient awareness and expectations, government initiatives, and growing demand for digital healthcare technology. The market is segmented by component, type, delivery mode, and by end-user. Some of the major players include MedMisr, Marsh, Cigna, Allianz and Accenture.
Egypt ENT Devices Market Analysis
Egypt's ENT Devices Market is projected to grow from $60 Mn in 2022 to $110 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Egypt ENT devices market include Alfa Medical, Al Amal Medical Supplies, and Misr Medicare.
Egypt Digital Health Market Analysis
Egypt's Digital Health market is projected to grow from $0.59Bn in 2022 to $2.56Bn by 2030, registering a CAGR of 20.1% during the forecast period of 2022-30. The market will be driven by the rise in consumer awareness of digital health technologies and the government's persuasion toward nationwide digitization. The market is segmented by solution, by deployment & by end-use. Some of the major players include GE Healthcare, Siemens Healthineers & Vezeeta.
Egypt Dialysis Market Analysis
This report presents a strategic analysis of the Egypt Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Dialysis Market, offering unmatched value, accuracy, and expert insights.
Egypt Diabetes Therapeutics Market Analysis
Egypt's diabetes therapeutics market is expected to witness growth from $403 Mn in 2022 to $942 Mn in 2030 with a CAGR of 11.2% for the forecasted year 2022-30. The higher prevalence rates of diabetes and the increased funding for the healthcare infrastructure in Egypt are responsible for the growth of the market. The Egypt diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Sovalue, Vortex Pharma, and AstraZeneca are the major players in the Egypt diabetes therapeutics market.
Egypt Diabetes Devices Market Analysis
Egypt's Diabetes Devices Market is expected to witness growth from $64 Mn in 2022 to $124 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. As healthcare expenditures in Egypt increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for healthcare goods in general, including diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include JK Medirise, EGMED, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
Egypt Coronary Stents Market Analysis
Egypt's Coronary Stents Market is expected to witness growth from $32 Mn in 2022 to $51 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. Increased investment in infrastructure, energy, and industry has contributed to Egypt's recent rapid economic expansion. This expansion offers manufacturers the chance to build their companies and enter new markets. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include JK Medirise, EGMED, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Egypt Contraceptive Devices Market Analysis
Egypt's Contraceptive Devices Market is expected to witness growth from $36 Mn in 2022 to $75 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Egypt's contemporary contraceptive prevalence rate reached 49.4% in 2020, although there is still tremendous space for market expansion. The market is segmented by type and by gender. Some key players in this market include Eva Pharma, Delta Pharma, Amoun Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
Egypt Cancer Immunotherapy Market Analysis
Egypt's cancer immunotherapy market is expected to witness growth from $315 Mn in 2022 to $610 Mn in 2030 with a CAGR of 8.6% for the forecasted year 2022-30. The rising prevalence of cancer and the improvements in healthcare spending in Egypt are responsible for the growth of the market. The Egypt cancer immunotherapy market is segmented by type, application, and end user. Pharco B, Amoun Pharmaceutical, and AstraZeneca are the major players in the Egypt cancer immunotherapy market.
Egypt Breast Cancer Therapeutics Market Analysis
Egypt's breast cancer therapeutics market is projected to grow from $51 Mn in 2022 to $149 Mn by 2030, registering a CAGR of 14.4% during the forecast period of 2022-30. Strong immunotherapeutic acceptance and favorable reimbursement policies in Egypt have led to the growth of Egypt's breast cancer therapeutics market. The market is segmented by therapy, by cancer type, and by distribution channel. MDI Pharma, Minapharm Pharmaceuticals, and Bristol-Myers Squibb are some leading companies in Egypt's breast cancer therapeutics market.
Egypt Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Egypt's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Egypt Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Egypt Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Antiviral Drugs Market, offering unmatched value, accuracy, and expert insights.
Egypt Over The Counter (OTC) Pharmaceuticals Market Analysis
Egypt's over-the-counter (OTC) pharmaceuticals market size was valued at $385 Mn in 2022 and is estimated to expand at a CAGR of 7.04% from 2022 to 2030 and will reach $663.5 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Egypt Pharmaceutical Market Analysis
This report presents a strategic analysis of the Egypt Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Pharmaceutical Market, offering unmatched value, accuracy, and expert insights.
Egypt Oncology Clinical Trials Market Analysis
Egypt's oncology clinical trials market is projected to grow from $35.4 Mn in 2022 to $60.9 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by Egypt's rising cancer incidence and the government's favorable regulatory framework for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International, EIPICO & EVA Pharma
Egypt Insulin Market Analysis
This report presents a strategic analysis of the Egypt Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Insulin Market, offering unmatched value, accuracy, and expert insights.
Egypt Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Egypt Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Diabetes Drugs Market, offering unmatched value, accuracy, and expert insights.
Egypt 3D Printing Medical Devices Market Analysis
Egypt's 3D Printing Medical Devices market size was valued at $8 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $31 Mn in 2030. The market is segmented by component, application, technology, and end user. The Egypt 3D Printing Medical Devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. T The key market players are Some of the key players in the market include MOBILIS Medical, NovaBone Products, E2E Medical, Human Technology Lab, SymmetrySurgical, Stratasys, Materialise, Stryker, and others.
Egypt Multiple Myeloma Therapeutics Market Analysis
Egypt's multiple myeloma therapeutics market was valued at $23 Bn in 2022 and is estimated to expand at a CAGR of 6% from 2022 to 2030 and will reach $37 Bn in 2030. One of the main reasons propelling the growth of this market is growing awareness and diagnosis, technological advancements. The market is segmented by type, drug, and distribution channel. Some key players in this market are EIPICO, Amoun Pharmaceutical Company, Pharco Pharmaceuticals, Delta Pharma, MEMI Pharmaceuticals, and others.
Egypt Uveitis Therapeutics Market Analysis
Egypt Uveitis therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Uveitis is an inflammation of the uvea, which is the middle layer of the tissue that surrounds the eye and is made up of the iris, ciliary body, and choroid. The most typical extra-articular Spondyloarthritis symptom is uveitis (SpA) Increased healthcare financing, together with the development of drugs with improved efficacy and fewer side effects, has benefited technological advancements in the field, which together are serving as a potential driver of the uveitis therapeutic market. Several well-known companies involved in the development and marketing of uveitis medicines include Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., and Allergan (now a division of AbbVie).
Egypt Anthrax Therapeutics Market Analysis
Egypt Anthrax therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Bacillus anthracis is the bacteria that causes anthrax (B. anthracis). The market for anthrax therapeutics is fueled by factors such the increased prevalence of bacterial infections, rising research funding, the development of innovative medicines for treating anthrax, and pipeline goods, which increase demand and stimulate market expansion. The current rise in healthcare spending in both developed and developing nations is anticipated to give manufacturers a competitive edge in the development of novel and ground-breaking products. Global industries in the Anthrax therapeutics market are Aristo Pharmaceuticals Private Limited, Indoco Remedies Ltd., Lupin, Deinove, Bayer AG, Pfizer Inc., Emergent, Soligenix, Zydus Group, Sanofi, Alembic Pharmaceuticals, Emergent, Sanofi, Porton Biopharma, Lupin, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd and many more
Egypt Colorectal Cancer Therapeutics Market Analysis
Egypt Colorectal Cancer Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Colon cancer, commonly known as colorectal cancer (CRC), is a condition that affects the large intestine. It is a type of cancer that develops in the colon or rectum. The surge in product introductions and colorectal cancer awareness are two factors driving the global market for drugs to treat the disease. The high incidence of colorectal cancer, which contributes to high mortality rates, and the rising global desire for more potent treatments are additional important driving forces. Genentech, Inc., Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Sanofi, Merck Sharp & Dohme Corp., Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.), Bayer AG, Regeneron Pharmaceuticals, Inc., Novartis AG, Ipsen Biopharmaceuticals, Inc., and numerous other global companies participate in the colorectal cancer therapeutics
Egypt Cryptococcosis Therapeutics Market Analysis
Egypt Cryptococcosis Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The pathogenic yeasts in the genus Cryptococcus that cause cryptococcosis have a wide range of clinical manifestations and are contagious throughout the world. Currently, Cryptococcus neoformans and Cryptococcus gattii are the two species of the bacteria most frequently linked to human illness. The market for disorders caused by cryptococcosis is expanding as a result of the rising prevalence of the condition and the availability of cutting-edge treatments. Bristol-Myers Squibb, Abbott Laboratories, Pfizer, Glenmark Pharmaceuticals, Bausch Health, Johnson & Johnson, Novartis AG, Janssen Biotech, Sigmapharm Laboratories, Matinas BioPharma, Mycovia Pharmaceuticals, Aparna Biosciences, FUJIFILM Toyama Chemical, TGV Therapeutics, Amplyx Pharmaceuticals, and many others are leading companies in the global market for Cryptococcosis therapeutics.
Egypt Cytomegalovirus Therapeutics Market Analysis
Egypt Cytomegalovirus Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A member of the Herpesviridae family with an envelope, the human herpesvirus 5 (HHV-5) is also referred to as cytomegalovirus. Around 40% to 100% of adults worldwide have experienced HHV-5 exposure at some point in their lifetime, making it a very common virus. A rise in the frequency of cytomegalovirus infection, investments in research & development, and the introduction of novel medicines are some of the reasons driving the growth of the market for cytomegalovirus therapeutics. Several Global pharmaceutical firms, including Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, MEMO Therapeutics, Lion TCR, and others are active in this Cytomegalovirus Therapeutics market.